Fresenius Kabi Netherlands
Miranda Heining currently serves as General Manager for Benelux at Fresenius Kabi Nederland, where a strategic plan was developed to drive profitability and achieve double-digit growth over several years. In addition to this role, Miranda acts as Commercial Director at Women on Wings and serves as an Expert Volunteer with VNFKD, where the focus is on supporting families in need. Miranda also holds the title of Vice President at the Dutch Association for Infant’s and Medical Nutrition, and is involved with FutureWomenX as a FutureMaker, dedicated to empowering women and fostering leadership. Earlier career experience includes positions as Chairperson at the Female Cancer Foundation and Marketing-Sales Director at Solvay Pharma, complemented by roles in qualitative market research. Academic credentials include a degree from Nyenrode Business University and ongoing studies in governance.
This person is not in any teams
This person is not in any offices
Fresenius Kabi Netherlands
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies. With its corporate philosophy of "Committed to Life", the company is committed to putting essential medicines and technologies in the hands of people who help patients and finding the best answers to the challenges they face. Fresenius Kabi employs about 40,500 people worldwide. In 2020, the company reported sales of around €7.0 billion. Fresenius Kabi AG is a wholly owned subsidiary of the Fresenius SE & Co. KGaA healthcare group. Fresenius Kabi is a global leader in our business segments. We offer employees of diverse cultures and backgrounds a wide range of fulfilling and challenging career and personal growth opportunities, both domestically and internationally. We work together in a spirit of partnership, personal commitment and integrity to create value. We offer: • world-class, dedicated teams • an open-minded, creative, can-do culture • a variety of opportunities to grow with the business • the chance to make a difference in patients’ quality of life Fresenius Kabi Community Guidelines and User Information: https://www.fresenius-kabi.com/documents/Community-Guidelines-and-User-Information-EN.pdf (English) https://www.fresenius-kabi.com/documents/Community-Guidelines-and-User-Information-DE.pdf (German)